The 21st International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2023) will be held 24-27 September 2023 in Oslo, Norway. IATDMCT 2023 will be the most important opportunity for experts in Therapeutic Drug Monitoring and Clinical Toxicology from the world to meet and discuss the innovations and problems in the field.

info@iatdmct.org  |  http://iatdmct2023.org/

Please save the dates to participate in our next IATDMCT Congress!

The special Membership Award includes free membership to IATDMCT & access to the TDM journal – period of 2 years, renewable once, several available for individuals residing in developing countries.

Enjoy all the valuable Membership Benefits, including online access to the Therapeutic Drug Monitoring (TDM) journal.

Get the complete Terms of Reference and learn how to apply today.

Deadline: July 31, 2023

At the 2023 IATDMCT Congress in Oslo, the venue for the 2027 Congress will be chosen.

Members interested in submitting a proposal to host the Congress must submit an application by July 31, 2023. The purpose of this application is to provide guidance for candidates and to facilitate the task of selecting the final site, for the Site Selection Committee. You may choose to submit the information required on the application form in a different format, but all questions on the form should be addressed. Very often a tourism office, conference centre, or hotel in the region can help you gather the information.

For more information on the application process, please contact: Congress Site Selection Committee

Click here to email your questions

Join us in maintaining the IATDMCT membership! We look forward to inspiring many further colleagues who share with us the idea of an optimized and personalized drug treatment to join us in IATDMCT. Please ensure you renew your membership in order to retain your IATDMCT member benefits.

Our 2023 Member-Get-A Member Campaign now is up and running! Members are invited to inform their colleagues (who are not members yet) about the benefits of membership. Let’s build a strong partnership together!

Campaign Deadline: August 31, 2023.

The top recruiter (with at least 50%-paying members) will gain a free registration for the IATDMCT Congress 2023 in Oslo.

Click here for complete participation details!

In this issue:

• Statistics of the Prague Congress
• Reports of the Scientific Committees
• Spotlight on New Members
• Weekend with scientific meetings in Madrid (October 7-8th): Update in Personalized Immunosuppression and TransplantCare, "A future full of hope"

Available in your choice of format:                  

Note: You must be logged in to access these download links.

Introducing: Eight Drugs a Week – an IATDMCT podcast! Join us every two months on your favourite podcast platform.

Some of the best talks at our congress in Prague last year were about the influence of gut microbiota on drug exposure. It feels recent work has brought us a lot closer to understand this, and how it may vary between drugs and individuals. Mycophenolate is a drug particularly affected and we are fortunate in this month’s blog to hear from Roland Lawson about his team’s work that has helped decipher the complexity behind the phenomenon, and also propose potential solutions to the problems it can cause for patients. This piece was originally published in December Compass, on behalf of the Immunosuppressive Drugs Committee.

Read more

Find the latest news and follow our IATDMCT institutional page on LinkedIn, Twitter @IATDMCT or Instagram!

Stay ahead with the latest scientific research developments in the fields of TDM and CT!

The monthly Therapeutic Drug Monitoring column provides you with the latest posts of ahead-of-print. Bringing to you articles posted online January 2 – 11, 2023:

ORIGINAL ARTICLES:

• Model-Informed Estimation of Acutely Decreased Tacrolimus Clearance and Subsequent Dose Individualization in a Pediatric Renal Transplant Patient With Posterior Reversible Encephalopathy Syndrome.
  Miyagawa, Bradley; Lazear, Danielle; Hooper, David K.; Vinks, Alexander A.; Mizuno, Tomoyuki.
  January 10, 2023
• Development and Validation of a Quantitative LC-MS/MS Method for CDK4/6 Inhibitors Palbociclib, Ribociclib, Abemaciclib, and Abemaciclib-M2 in Human Plasma.
  Burke, Sarah M.; Kamal, Mustafa; Goey, Andrew K. L.
  January 10, 2023
• Area-Under-Curve–Guided Versus Trough-Guided Monitoring of Vancomycin and Its Impact on Nephrotoxicity: A Systematic Review and Meta-Analysis.
  Lim, Ashley Shiyuan; Foo, Sharlene Hui Wen; Benjamin Seng, Jun Jie; Magdeline Ng, Tao Tao; Chng, Hui Ting; Han, Zhe.
  January 10, 2023

REVIEW ARTICLE:

• Use of Therapeutic Drug Monitoring in Amiodarone Treatment: A Systematic Review of Recent Literature.
  Jørgensen, Adam El Mongy; Hermann, Thomas Steffen; Christensen, Hanne Rolighed; Dalhoff, Kim Peder.
  January 11, 2023
• Optimum Methotrexate Exposure in Patients With Suspected or Confirmed CNS Invasive Hematological Malignancies: A Systematic Critical Review.
  Faria, Monteiro Joaquim; Rita, Damas; Rui, Bergantim; Fernanda, Trigo.
  January 10, 2023
• Volumetric Absorptive Microsampling to Enhance the Therapeutic Drug Monitoring of Tacrolimus and Mycophenolic Acid: A Systematic Review and Critical Assessment.
  Leino, Abbie D.; Takyi-Williams, John; Pai, Manjunath P.
  January 3, 2023
• Optimization of Antimicrobial Stewardship Programs Using Therapeutic Drug Monitoring and Pharmacokinetics–Pharmacodynamics Protocols: A Cost-Benefit Review.
  Telles, João Paulo; Morales, Ronaldo Jr; Yamada, Carolina Hikari; Marins, Tatiana A.; D'Amaro Juodinis, Vanessa; Sztajnbok, Jaques; Silva, Moacyr Jr; Bassetti, Bil Randerson; Albiero, James; Tuon, Felipe Francisco.
  January 3, 2023

GRAND ROUNDS:

• Successful and Safe Real-Time TDM-Guided Treatment of Invasive Pulmonary and Cerebral Aspergillosis Using Low-Dose Isavuconazole in a Patient with Primary Biliary Cirrhosis: Grand Round/A Case Study.
  Cojutti, Pier Giorgio; Rinaldi, Matteo; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico.
  January 3, 2023
• An Unusual Case of Low Vancomycin Exposure Despite Extremely High Vancomycin Doses Accompanied by Renal Toxicity: A Grand Round.
  van Schip, Anne M.; van Diemen, Jeske J. K.; van Hest, Reinier M.; Harris, Vanessa C.
  January 2, 2023

SHORT COMMUNICATION:

• Evaluation of Limited Sampling Strategies for Bayesian Estimation of Daptomycin Area Under the Concentration–Time Curve: A Short Communication.
  Tuloup, Vianney; Millet, Aurélien; Taricco, Alessandra; Parant, François; Ferry, Tristan; Goutelle, Sylvain.
  January 3, 2023

LETTER TO THE EDITOR:

• Tenofovir Plasma Trough Concentrations in People Living with HIV Treated with Tenofovir Disoproxyl Fumarate: Antiretroviral Class or Individual Drug Effect?.
  Cattaneo, Dario; Bonora, Stefano; Meraviglia, Paola; Vimercati, Stefania; Antinori, Spinello; Gervasoni, Cristina.
  January 10, 2023

››Submit your high quality research – Information for authors.

The Communication Committee would like to inform the membership that advertisements for professional positions (Ph.D. and Post-Doc job opportunities) in the field of TDM/CT, will be published in the E-news instead of on the IATDMCT website. Please e-mail the office with the advertisement for the position and it will be published in an upcoming monthly E-news. (IATDMCT office email: info@iatdmct.org)

The Communication Committee is also working in IATDMCT Website frames settings to provide better service to members.

» Click here to Post an Event on our Online Events Calendar today!

Visit the IATDMCT Events Calendar and stay informed about the upcoming TDM and CT Meetings. By doing this you can comfortably and directly reach all related online resources.

Co-editor: Manuela Neuman
Co-editor: Ryuji Kato
Co-editor: Miao Yan

NOTE: Items appearing in the IATDMCT monthly E-News do not necessarily have the endorsement of the Association.